Suchergebnisse - "Cavallari, Larisa H"

PubPharm (28)

1

Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2023

von Cicali, E. | Elchynski, A. | Thomas, C. | +8

2

Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention

enthalten in: Clinical pharmacology and therapeutics | 2023

von Cavallari, L. | Limdi, N. | Beitelshees, A. | +19

3

Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI : A Multi-Site, Real-World Investigation

enthalten in: Clinical pharmacology and therapeutics | 2022

von Thomas, C. | Franchi, F. | Keeley, E. | +19

4

CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings

enthalten in: Journal of the American Heart Association | 2022

von Beitelshees, A. | Thomas, C. | Empey, P. | +22

5

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

enthalten in: Clinical and translational science | 2022

von Tuteja, S. | Salloum, R. | Elchynski, A. | +26

6

Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease

enthalten in: The pharmacogenomics journal | 2021

von Elchynski, A. | Cicali, E. | Ferrer Del Busto, M. | +10

7

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

enthalten in: Clinical pharmacology and therapeutics | 2021

von Lima, J. | Thomas, C. | Barbarino, J. | +17

8

Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

enthalten in: Clinical pharmacology and therapeutics | 2021

von Lee, C. | Thomas, C. | Beitelshees, A. | +22

9

PharmVar GeneFocus : CYP2C19

enthalten in: Clinical pharmacology and therapeutics | 2021

von Botton, M. | Whirl-Carrillo, M. | Del Tredici, A. | +12

10

Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2020

von Beitelshees, A. | Stevenson, J. | El Rouby, N. | +14

ErratumIn: Genet Med. 2020 Aug 3;:. - PMID 32747766